Cargando…

The Role of Systolic Blood Pressure Reduction in Diastolic Dysfunction: RAAS Inhibition versus Non-RAAS Blood Pressure Lowering

Detalles Bibliográficos
Autor principal:	Park, Sung-Ji
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Korean Society of Echocardiography 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316557/ https://www.ncbi.nlm.nih.gov/pubmed/32583634 http://dx.doi.org/10.4250/jcvi.2020.0083

Ejemplares similares

Blood pressure reduction and RAAS inhibition in diabetic kidney disease: therapeutic potentials and limitations
por: Leoncini, Giovanna, et al.
Publicado: (2020)

Gastrodin Reduces Blood Pressure by Intervening with RAAS and PPARγ in SHRs
por: Liu, Wei, et al.
Publicado: (2015)

Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy
por: Ghazi, Lama, et al.
Publicado: (2017)

RAAS inhibition and mortality in hypertension
por: Ferrari, Roberto
Publicado: (2013)

Comparison of Severity of COVID-19 Infection among Patients Using RAAS Inhibitors and Non-RAAS Inhibitors
por: Reddy, Paidi Ramakrishna, et al.
Publicado: (2021)

The RAAS Goodfellas in Cardiovascular System
por: Caputo, Ilaria, et al.
Publicado: (2023)

COVID-19 and the RAAS—a potential role for angiotensin II?
por: Busse, Laurence W., et al.
Publicado: (2020)

Control Rates of Systolic and Diastolic Blood Pressure among Hypertensive Adults in Korea
por: Hisamatsu, Takashi
Publicado: (2019)

Antifibrotic Roles of RAAS Blockers: Update
por: Zhang, Ying-Ying, et al.
Publicado: (2019)

Non-Invasive Estimation of Systolic Blood Pressure and Diastolic Blood Pressure Using Photoplethysmograph Components
por: Jeong, Incheol, et al.
Publicado: (2010)

Clinical significance of central systolic blood pressure in LV diastolic dysfunction and CV mortality
por: Choi, Sun Ryoung, et al.
Publicado: (2021)

Elevated On-Treatment Diastolic Blood Pressure and Cardiovascular Outcomes in the Presence of Achieved Systolic Blood Pressure Targets
por: Kim, Dae-Hee, et al.
Publicado: (2022)

A Shot in the Dark! RAAS Inhibitors Cause Severe COVID-19 Infection
por: Krishna, Bhuvana
Publicado: (2021)

Heavy Ion RAA summary Plots 2022
por: The ATLAS collaboration
Publicado: (2022)

RAAS-Blockade in COVID-19: The Ace of Spades?
por: Agarwal, Krishna A., et al.
Publicado: (2021)

RAAS INHIBITORS ARE CARDIOPROTECTIVE IN PATIENTS WITH COVID-19
por: Holmes, Adam R., et al.
Publicado: (2021)

Development and Application of RAA Nucleic Acid Test Strip Assay and Double RAA Gel Electrophoresis Detection Methods for ASFV and CSFV
por: Wu, Keke, et al.
Publicado: (2022)

Prediction of cardiovascular events from systolic or diastolic blood pressure
por: Talebi, Atefeh, et al.
Publicado: (2022)

Eplerenone Implantation Improved Adipose Dysfunction Averting RAAS Activation and Cell Division
por: Vecchiola, Andrea, et al.
Publicado: (2020)

Optimal systolic and diastolic blood pressure threshold that associated with lower risk of white matter hyperintensity progression
por: Liu, Sibo, et al.
Publicado: (2023)

Effect of RAAS Inhibition on the Incidence of Cancer and Cancer Mortality in Patients with Glomerulonephritis
por: Chin, Ho Jun, et al.
Publicado: (2011)

The other possible mechanism of the benefits of RAAS inhibition in the athogenesis of COVID‐19
por: Gupta, Neelesh, et al.
Publicado: (2020)

Gender-specific differences in associations between economic status and systolic blood pressure or diastolic blood pressure
por: Li, Jun, et al.
Publicado: (2020)

Using Mean Arterial Pressure in Hypertension Diagnosis versus Using Either Systolic or Diastolic Blood Pressure Measurements
por: Kandil, Heba, et al.
Publicado: (2023)

Angiotensin receptor neprilysin inhibition versus individualized RAAS blockade: design and rationale of the PARALLAX trial
por: Wachter, Rolf, et al.
Publicado: (2020)

On-Treatment Diastolic Blood Pressure: When Is It Too High?
por: Park, Jin Joo
Publicado: (2022)

Heavy Ion Jet RAA Summary Plots 2023
por: The ATLAS collaboration
Publicado: (2023)

Update on RAAS Modulation for the Treatment of Diabetic Cardiovascular Disease
por: Bernardi, Stella, et al.
Publicado: (2016)

Novel RAAS agonists and antagonists: clinical applications and controversies
por: Romero, Cesar A., et al.
Publicado: (2015)

Renal Modulation: The Renin-Angiotensin-Aldosterone System (RAAS)
por: Natarajan, Aruna, et al.
Publicado: (2008)

RAAS inhibitors do not increase the risk of COVID-19
por: Fernández-Ruiz, Irene
Publicado: (2020)

COVID-19 and RAAS inhibitors: is there a final conclusion?
por: Talebi-Taher, Mahshid, et al.
Publicado: (2021)

RAAS inhibitors in COVID-19: not all are created equal!
por: Kow, Chia Siang, et al.
Publicado: (2023)

Dietary Influence on Systolic and Diastolic Blood Pressure in the TwinsUK Cohort
por: Louca, Panayiotis, et al.
Publicado: (2020)

Ratio of diastolic to systolic blood pressure represents renal resistive index
por: Akaishi, Tetsuya, et al.
Publicado: (2019)

Solar Activity Is Associated With Diastolic and Systolic Blood Pressure in Elderly Adults
por: Wang, Veronica A., et al.
Publicado: (2021)

Not afraid of low diastolic blood pressure anymore?
por: Siński, Maciej, et al.
Publicado: (2019)

Clinical Utility of Blood Pressure Measurement Using the Newer Palpatory Method for Both Systolic and Diastolic Blood Pressure
por: Danish, Mohammad, et al.
Publicado: (2020)

Midlife blood pressure predicts future diastolic dysfunction independently of blood pressure
por: Ghosh, Arjun Kumar, et al.
Publicado: (2016)

Aliskiren, Fosinopril, and Their Outcome on Renin-Angiotensin-Aldosterone System (RAAS) in Rats with Thyroid Dysfunction
por: Farhadi, Susan A. S., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_31n5q94qkf7ogg4vvmpa5vsi7r